Archive | Oral Cancer News RSS feed for this section

New oral cancer treatment used in study shrank tumors in mice by half

22. September 2016

0 Comments

Source: www.ksat.com Author: Courtney Friedman – VJ, Reporter Oral cancer is a scary diagnosis. Sixty percent of people are diagnosed in a late stage of the disease, meaning their survival rate is below 50 percent. “These statistics have not changed in over 40 years, because there’s not been any new therapies that target oral cancers,” […]

Continue reading...

HPV symptoms and health consequences

20. September 2016

0 Comments

Source: www.kristv.com Author: Roland Rodriguez No one dreams of walking into his or her doctor’s office and hearing the words “you have been diagnosed with human papillomavirus, or HPV.” Unfortunately, this scenario is all too real. HPV is the most common sexually-transmitted infection (STI) in the United States. In fact, it’s so common that nearly […]

Continue reading...

Incisionless robotic surgery offers promising outcomes for oropharyngeal cancer patients

18. September 2016

0 Comments

Source: medicalxpress.com Author: press release, Henry Ford Health System A new study from researchers at Henry Ford Hospital finds an incisionless robotic surgery – done alone or in conjunction with chemotherapy or radiation – may offer oropharyngeal cancer patients good outcomes and survival, without significant pain and disfigurement. Patients with cancers of the base of […]

Continue reading...

Why men need to start caring about HPV

11. September 2016

0 Comments

Source: www.refinery29.com Author: Sarah Jacoby The human papillomavirus (HPV) is one of very few STIs that we have a vaccine for. And — bonus! — that vaccine prevents cancer. But a report from the U.S. Centers for Disease Control and Prevention (CDC) released last month indicated that although we’ve made some improvements in the vaccination […]

Continue reading...

Chronic sinusitis linked to head and neck cancers in elderly

11. September 2016

0 Comments

Source: www.cancernetwork.com Author: Anna Azvolinsky Chronic sinusitis is associated with three rare types of head and neck cancer, including nasopharyngeal cancer, human papillomavirus (HPV)-related oropharyngeal cancer, and nasal cavity and paranasal sinus cancers, according to a new study published in JAMA Otolaryngology–Head & Neck Surgery. Chronic sinusitis is local inflammation caused by either a virus […]

Continue reading...

Impact of cancer screening in California over past 15 years

5. September 2016

0 Comments

Source: www.sciencedaily.com Author: University of California – Davis Health System A new report from the UC Davis Institute for Population Health Improvement (IPHI) shows the impact of cancer screening over the past 15 years, identifying areas where increased screening and other cancer-control efforts would save lives and significantly benefit population health. The CalCARES report uses […]

Continue reading...

Google and UCLH to develop AI to improve cancer therapies

5. September 2016

0 Comments

Source: www.phgfoundation.org Author: Julian Harris Google’s Artificial Intelligence research group announced a new partnership with University College London Hospitals, applying machine learning to radiotherapy treatment for head and neck cancer. The new partnership is the third since the launch of DeepMind’s health division in February 2016. The partnership aims to assist clinicians in the segmentation […]

Continue reading...

Expert Asserts Pembrolizumab to Play Important Role in Head and Neck Cancer Treatment

1. September 2016

0 Comments

Source: www.targetedonc.com Author: Laura Panjwani The FDA approval of pembrolizumab (Keytruda) as a treatment for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) in August 2016 was extremely significant for this patient population, which previously had limited options following progression on a platinum-based chemotherapy. The approval was based on the phase […]

Continue reading...

New method of cancer immunotherapy developed

25. August 2016

0 Comments

Source: www.nextbigfuture.com Author: staff A team of Stanford ChEM-H scientists has discovered a novel form of cancer immunotherapy, which works by removing certain sugars from the surface of cancer cells and making those cells visible to the immune system. Scientists have long known that if certain sugars are present on a tumor, it is less […]

Continue reading...

Expert says Nivolumab Poised to Change Standard of Care in SCCHN

24. August 2016

0 Comments

Source: www.onclive.com Author: Laura Panjwani Nivolumab (Opdivo) is a game-changing agent for the treatment of patients with squamous cell carcinoma of the head and neck (SCCHN), according to Robert L. Ferris, MD, PhD. “Recent findings have shown us that this agent is really the new standard-of-care option for all platinum-refractory patients with head and neck […]

Continue reading...